These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33677052)

  • 81. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
    Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
    Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents.
    Gersten BK; Fitzgerald TS; Fernandez KA; Cunningham LL
    J Assoc Res Otolaryngol; 2020 Aug; 21(4):303-321. PubMed ID: 32583132
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Risk factors associated with cisplatin-induced ototoxicity in Japanese patients with solid tumors.
    Okada H; Kitagawa K
    Cancer Med; 2023 Apr; 12(7):7904-7910. PubMed ID: 36567514
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Ototoxic effect of cisplatin in children with brain tumors.
    Cohen BH; Zweidler P; Goldwein JW; Molloy J; Packer RJ
    Pediatr Neurosurg; 1990-1991; 16(6):292-6. PubMed ID: 2134738
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
    Clemens E; Brooks B; de Vries ACH; van Grotel M; van den Heuvel-Eibrink MM; Carleton B
    PLoS One; 2019; 14(2):e0210646. PubMed ID: 30763334
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
    Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
    Tan WJT; Vlajkovic SM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003734
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
    Allen GC; Tiu C; Koike K; Ritchey AK; Kurs-Lasky M; Wax MK
    Otolaryngol Head Neck Surg; 1998 May; 118(5):584-8. PubMed ID: 9591854
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    Paken J; Govender CD; Pillay M; Feyasa M; Sewram V
    PLoS One; 2023; 18(4):e0283639. PubMed ID: 37014872
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cisplatin ototoxicity in children: a practical grading system.
    Brock PR; Bellman SC; Yeomans EC; Pinkerton CR; Pritchard J
    Med Pediatr Oncol; 1991; 19(4):295-300. PubMed ID: 2056973
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
    Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
    Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach.
    Orgel E; Jain S; Ji L; Pollick L; Si S; Finlay J; Freyer DR
    Pediatr Blood Cancer; 2012 Jun; 58(6):953-8. PubMed ID: 21796767
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients.
    Camet ML; Spence A; Hayashi SS; Wu N; Henry J; Sauerburger K; Hayashi RJ
    Front Oncol; 2021; 11():673080. PubMed ID: 34262862
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
    Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
    Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cisplatin-induced ototoxicity in pediatric solid tumors: the role of glutathione S-transferases and megalin genetic polymorphisms.
    Choeyprasert W; Sawangpanich R; Lertsukprasert K; Udomsubpayakul U; Songdej D; Unurathapan U; Pakakasama S; Hongeng S
    J Pediatr Hematol Oncol; 2013 May; 35(4):e138-43. PubMed ID: 23274376
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC; Collopy C; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2021 Feb; 147(2):182-189. PubMed ID: 33300954
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R; Ruckenstein MJ; Leake F; Steere E; Robbins KT
    Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):978-81. PubMed ID: 9305250
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.
    Li Y; Womer RB; Silber JH
    Eur J Cancer; 2004 Nov; 40(16):2445-51. PubMed ID: 15519518
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens.
    Kolinsky DC; Hayashi SS; Karzon R; Mao J; Hayashi RJ
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):119-23. PubMed ID: 20098336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.